FDA Adverse Event Injury Summary report: N

SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE

MDR report key: 3953423 · Received July 23, 2014

Report

Report Number
1416980-2014-23895
Event Type
Injury
Date Received
July 23, 2014
Date of Event
June 28, 2014
Report Date
June 28, 2014
Manufacturer
BAXTER HEALTHCARE CORPORATION
Product Code
KDJ
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
KS
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4). AS THE SAMPLE WAS NOT RETURNED AND THE LOT NUMBER IS UNKNOWN, A DEVICE ANALYSIS CANNOT BE COMPLETED. SHOULD ADDITIONAL RELEVANT INFORMATION BECOME AVAILABLE, A FOLLOW-UP REPORT WILL BE SUBMITTED.

Description of Event or Problem · 1

IT WAS REPORTED THAT A PATIENT EXPERIENCED PERITONITIS COINCIDENT WITH CONTINUOUS AMBULATORY PERITONEAL DIALYSIS (CAPD) THERAPY. THE CAUSE OF THE PERITONITIS WAS UNKNOWN. THE PATIENT WAS HOSPITALIZED FOR THE EVENT WITH SYMPTOMS OF FEVER, ABDOMINAL PAIN, AND CLOUDY EFFLUENT. THE PATIENT WAS TREATED WITH INTRAPERITONEAL (IP) CEFAMEZIN INJECTIONS (250MG FOUR TIMES A DAY) AND IP TAZIM INJECTIONS (250MG FOUR TIMES A DAY) FOR THE EVENT. AT THE TIME OF THIS REPORT, THE PATIENT REMAINED HOSPITALIZED WITH ONGOING TREATMENT. THE PATIENT HAD NOT YET RECOVERED FROM THE PERITONITIS. CAPD THERAPY WAS REPORTED TO BE ONGOING. ADDITIONAL INFORMATION WAS REQUESTED BUT IS NOT AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
430462 SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE KDJ BAXTER HEALTHCARE CORPORATION

Patients

Seq Age Sex Outcome Treatment
1 35 YR Hospitalization| R PHYSIONEAL AND EXTRANEAL